Magnetic Seizure Therapy Effective in Treating Suicidality
Low- and moderate-frequency magnetic seizure therapy help patients with treatment-resistant depression go into remission.
Read More
Providers Not Following Food Allergy Guidelines for Infants
The findings suggest the need to possibly revise published food allergy guidelines.
Jeff Stark, MD: How ICD-10 Codes Affect nr-ax-SpA Treatment
Jeff Stark, MD, discusses how ICD-10 codes for nr-ax-SpA affect patients and providers.
Secnidazole Effective for Trichomoniasis
Findings of a new phase 3 trial support the use of secnizadole in patients with trichomoniasis.
Flu Vaccination Rates Lower Among Minority Patients
Racial disparities exist among patients receiving dialysis.
Jeff Stark, MD: The Process of nr-ax-SpA Indexed to ICD-10
Jeff Stark, MD, discusses why nr-ax-SpA wasn't indexed and the process of having it included as an ICD-10 code.
Jeff Stark, MD: The Importance of ICD-10 Codes for nr-ax-SpA
With nr-ax-SpA newly identified as an ICD-10 code, Jeff Stark, MD, discusses why this is so important for patients and clinicians alike.
Medical Marijuana Reduces Hospital Visits Among Sickle Cell Disease Patients
The findings can lead to an alternative pain option for patients with sickle cell disease.
Topical Calcineurin Inhibitors Not Linked With Increased Risk of Keratinocyte Carcinoma
The study addresses safety concerns related to the risk of keratinocyte carcinoma for patients with atopic dermatitis.
ESC Releases Guidelines on Acute Pulmonary Embolism Management
Guideline adoption could lead to more use of thrombolytic therapy.
Opioid Prescriptions Increase Risk of Substance-Related Morbidity
Additional monitoring is needed among patients receiving opioid therapy.
Less COPD Exacerbation Risks for Tiotropium Plus Olodaterol
Tiotropium plus olodaterol is more effective for patients with COPD compared with LABA plus inhaled corticosteroids.
Benralizumab Safe, Effective for Asthma Patients
Results of ANDHI provide additional support on the safety and efficacy of benralizumab for patients with asthma.
Dupilumab Reduces Asthma Exacerbation Rates
Dupilumab significantly reduces exacerbation rates in patients with asthma compared to standard of care.
DOACs in Obese Patients Show Similar VTE Recurrence Rates to Non-Obese Patients
The study paves the way for prospective multi-institutional randomized control trials to further re-enforce the safe use of direct oral anticoagulants in patients with obesity.
Manipulative Therapy Ineffective for Chronic Low Back Pain
Manipulative techniques are not effective for chronic low back pain among relatively young individuals.
DDP-4 Inhibitors Increase Risk of Bullous Pemphigoid
Older, white patients and those who use linagliptin are at a higher risk of bullous pemphigoid.
Denosumab Doses Must Be Delivered On Time for Patients With Osteoporosis
It is important for clinicians considering prescribing denosumab treatment to counsel patients before its initiation on the importance of not delaying or discontinuing injections.
Canakinumab Beneficial in Treating Osteoarthritis
FDA Approves Epidiolex CBD to Treat Seizures Associated with Tuberous Sclerosis Complex
The FDA approved the CBD solution following the results of a randomized, double-blind, placebo-controlled trial.
Opioids Overprescribed After Total Hip or Knee Arthroplasty
Policies must change to curb postoperative opioid overprescribing.
Eugenia South, MD, MSHP: COVID-19 and Nature
Being outside is safer than being inside with a lot of people.
Eugenia South, MD, MSHP: Nature and the Role of the Provider
Pediatrics is leading the way in prescribing nature.
Kim Kjoller, MD: BLA for Tralokinumab and the Next Steps
The FDA will be working over the next few months to ensure tralokinumab is efficient for atopic dermatitis.
Kim Kjoller, MD: Comparing Tralokinumab to Other Agents for Atopic Dermatitis
An expert explains differences between tralokinumab and other popular agents for atopic dermatitis.
Model Accurately Predicts Benefit of Lipid-Lowering Therapies
The model can simulate treatment benefit over time with time-varying low-density lipoprotein cholesterol.
Dexamethasone Implant and Anti-VEGF Therapy Effective for NAMD
Combining the dexamethasone implant with anti-VEGF treatment can restore foveal anatomy in eyes resistant to anti-VEGF injection.
Upadacitinib Plus Topical Corticosteroids Effective for Atopic Dermatitis
The data from the phase 3 AD Up trial add to existing knowledge of the efficacy and safety of upadacitinib for patients with atopic dermatitis.
Moderate to Severe NPDR Leads to Greater Risk of Vision-Threatening DR
Eyes with moderate to severe nonproliferative diabetic retinopathy more often develop eye worsening compared to those with a milder form of the condition.
Strategies Needed to Improve Visual Acuity for Diabetic Macular Edema
Patients demonstrate visual gains from baseline but mean visual acuity worsens between 2 and 5 years.